Table 2.
[9a] (μM) | Overnight incubation at 25°C | 2 hr incubation at 37°C | ||
---|---|---|---|---|
KM (μM) | VMAX (mAU/min) | KM (μM) | VMAX (mAU/min) | |
|
|
|||
0 | 9.5 ± 1.8b | 81 ± 5 | 7.7 ± 2.0 | 86 ± 7 |
0.36 | 11.1 ± 2.5 | 80 ± 6 | –c | – |
0.63 | 7.7 ± 1.3 | 69 ± 3 | 6.7 ± 2.3 | 72 ± 8 |
1.53 | – | – | 2.2 ± 0.8 | 30 ± 2 |
1.80 | 3.2 ± 0.5 | 35 ± 1 | – | – |
3.60 | 3.1 ± 0.60 | 19 ± 1 | 2.7 ± 0.6 | 25 ± 1 |
9.90 | – | – | 1.9 ± 0.6 | 15 ± 0.8 |
KM and VMAX were measured by monitoring the initial rate of thrombin hydrolysis of Spectrozyme TH (2 – 80 μM) from the linear increase in absorbance at 405 nm in the presence of fixed concentration of 9a that was incubated either overnight at 25°C or for two hours at 37°C in 20 mM Tris-HCl buffer, pH 7.4, containing 100 mM NaCl, 2.5 mM CaCl2 and 0.1 % PEG8000. The data was fitted by the standard Michaelis – Menten equation to obtain KM and VMAX, as described in ‘Experimental Procedures’.
Error represents ±1 S.E.
Not measured